Molecular and Clinical Features of FLT3 Juxtamembrane Domain Point Mutations in Acute Myeloid Leukemia (AML) (Alliance
- Citation:
- Blood vol 140 (suppl 1) 6244–6
- Meeting Instance:
- ASH 2022
- Year:
- 2022
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Leuk Corr Sci
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171;
- Corr. Author:
- Authors:
- Nadeen Anabtawi Jessica Kohlschmidt Daelynn R. Buelow Shelley J. Orwick Kennedy Coleman Krzysztof Mrózek Jonathan E. Koliz Bayard L. Powell William G. Blum Maria R. Baer John C. Byrd Wendy Stock Geoffrey Uy Ann-Kathrin Eisfeld Sharyn D. Baker James S. Blachly
- Networks:
- LAPS-IL057, LAPS-MO011, LAPS-OH007, MD015, NC002, OH070
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-20202, CALGB-8461, CALGB-9665
- Phases:
- N/A
- Keywords: